fluoxetine has been researched along with melatonin in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (3.85) | 18.7374 |
1990's | 11 (21.15) | 18.2507 |
2000's | 14 (26.92) | 29.6817 |
2010's | 21 (40.38) | 24.3611 |
2020's | 4 (7.69) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Dutour, R; Poirier, D | 1 |
Feng, F; He, S; Jiang, H; Jiang, X; Liu, W; Qu, W; Sun, H; Zhou, J | 1 |
Pavel, S | 1 |
Olcese, JM | 1 |
Allen, NH; Childs, PA; Martin, NJ; Plaskett, L; Rodin, I; Smythe, PJ; Thompson, C | 1 |
Bialik, RJ; Brown, GM; Lapierre, YD; Ravindran, AV | 1 |
Maj, M; Monteleone, P; Natale, M; Orazzo, C | 1 |
Adler, L; Huether, G; Poeggeler, B; Rüther, E | 1 |
Míguez, JM; Pévet, P; Simonneaux, V | 1 |
Catapano, F; Di Martino, S; Maj, M; Monteleone, P; Tortorella, A | 1 |
deVries, MW; Peeters, FP | 1 |
Daya, S; Walsh, HA | 1 |
Dolberg, OT; Grunhaus, L; Hirschmann, S | 1 |
Amado, I; Bogdan, A; Bourdel, MC; Hantouche, EG; Millet, B; Olié, JP; Poirier, MF; Touitou, Y | 1 |
Delagrange, P; Kopp, C; Misslin, R; Rettori, MC; Vogel, E | 1 |
Barr, AM; Brotto, LA; Gorzalka, BB | 1 |
Dannon, PN; Dolberg, OT; Grunhaus, L; Hirschman, S; Schreiber, S | 1 |
Newton, RP; Parry, BL | 1 |
Garg, V; Gupta, S; Kulkarni, SK; Singh, A | 1 |
Abdel-Salam, OM; Arbid, MS; Baiuomy, AR | 1 |
Akhisaroglu, M; Dimitrijevic, N; Imbesi, M; Kurtuncu, M; Manev, H; Uz, T | 1 |
Chien, C; Gruber, N; Kennaway, DJ; McMillen, IC; Morrison, JL; Riggs, KW; Rurak, DW | 1 |
Bao, AM; Liu, YJ; Tan, ZL; Zhao, GQ; Zhou, JN | 1 |
Brang, D; Ramachandran, VS | 1 |
Barton, R | 1 |
Carvalho, LA; Gorenstein, C; Markus, RP; Moreno, R; Pariante, C | 1 |
Pennington, PL; Sapozhnikova, Y; Winder, VL; Wirth, EF | 1 |
Andrade, C; Bhakta, SG | 1 |
Alcalde, AI; Iceta, R; Matheus, N; Mendoza, C; Mesonero, JE | 1 |
Binfaré, RW; Budni, J; Mantovani, M; Rodrigues, AL; Santos, AR | 1 |
Al-Khalifa, II; Gorial, FI; Hussain, SA; Jasim, NA | 1 |
Corbach-Söhle, S; Flügge, G; Fuchs, E; Kohlhause, S; Schlumbohm, C; Schmelting, B | 1 |
Degirmencioglu, S; Gurbuz, ZG; Kirecci, SL; Mimaroglu, S; Simsek, A; Vural, P; Yuksel, A | 2 |
Sato, Y | 1 |
Amano, T | 1 |
Cantrell, SE; Häuser, W; Nishishinya, MB; Urrútia, G; Walitt, B | 1 |
Blonska, A; Chojnacki, C; Chojnacki, J; Klupinska, G; Pawlowicz, M; Walecka-Kapica, E | 1 |
Armitage, R; Bertram, H; Burgess, HJ; Dopp, R; Hoffmann, R; Huntley, ED; Mooney, A; Swanson, LM; Todd Arnedt, J; Zollars, J | 1 |
Khaksar, M; Oryan, A; Rahbarghazi, R; Rezabakhsh, A; Sayyari, M | 1 |
Boudah, A; Jasmin, L; Rebai, R | 1 |
Ji, YT; Li, K; Li, XY; Shen, S; Wang, XD; Zhang, LS | 1 |
Gilron, I; Moore, RA; Shum, B; Thorpe, J; Wiffen, PJ | 1 |
Bernardo, CO; Gonzalez-Chica, DA; Jureidini, J; Klau, J; Raven, M | 1 |
Chen, AQ; Fan, ZX; Hao, MX; He, SM; Liu, HR; Liu, W; Lv, SJ; Qiu, CZ; Ren, DL; Wei, ML; Yin, ZJ; Zhang, L | 1 |
Agarwal, SM; Ahsan, ZA; Cohn, T; Duncan, MJ; Faulkner, GEJ; Hahn, M; Lockwood, JT; Remington, G; Stogios, N; Takeuchi, H; Taylor, VH | 1 |
Anand, V; Campbell, S; Otten, H | 1 |
7 review(s) available for fluoxetine and melatonin
Article | Year |
---|---|
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms.
Topics: Animals; Drug Combinations; Drug Delivery Systems; Drug Design; Humans; Ligands | 2019 |
Chronobiological basis of female-specific mood disorders.
Topics: Antidepressive Agents, Second-Generation; Chronobiology Phenomena; Cross-Over Studies; Depression, Postpartum; Estrogens; Female; Fluoxetine; Humans; Light; Melatonin; Menopause; Mood Disorders; Pregnancy; Premenstrual Syndrome; Puberty; Sleep | 2001 |
Use of medication in children with psychiatric disorders.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom | 2007 |
Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Topics: Amitriptyline; Citalopram; Fibromyalgia; Fluoxetine; Humans; Melatonin; Musculoskeletal Pain; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Syndrome | 2015 |
Combination pharmacotherapy for the treatment of fibromyalgia in adults.
Topics: 5-Hydroxytryptophan; Acetaminophen; Adult; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Benzodiazepines; Carisoprodol; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Fluoxetine; Humans; Magnesium; Malates; Melatonin; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Pregabalin; Randomized Controlled Trials as Topic | 2018 |
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Topics: Antipsychotic Agents; Betahistine; Famotidine; Fluoxetine; Humans; Melatonin; Metformin; Nausea; Nizatidine; Ranitidine; Reboxetine; Schizophrenia; Topiramate; Weight Gain | 2022 |
10 trial(s) available for fluoxetine and melatonin
Article | Year |
---|---|
Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment.
Topics: Adult; Circadian Rhythm; Female; Fluoxetine; Humans; Hydrocortisone; Male; Melatonin; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 1995 |
Melatonin for the treatment of sleep disturbances in major depressive disorder.
Topics: Adult; Aged; Ambulatory Care; Analysis of Variance; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Humans; Melatonin; Middle Aged; Placebos; Psychiatric Status Rating Scales; Sleep Wake Disorders; Treatment Outcome | 1998 |
Coadministration of melatonin and fluoxetine does not improve the 3-month outcome following ECT.
Topics: Aged; Bipolar Disorder; Combined Modality Therapy; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electroconvulsive Therapy; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Melatonin; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Treatment Outcome | 2001 |
Chronobiological basis of female-specific mood disorders.
Topics: Antidepressive Agents, Second-Generation; Chronobiology Phenomena; Cross-Over Studies; Depression, Postpartum; Estrogens; Female; Fluoxetine; Humans; Light; Melatonin; Menopause; Mood Disorders; Pregnancy; Premenstrual Syndrome; Puberty; Sleep | 2001 |
Effect of fluoxetine on circadian rhythm of melatonin in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Circadian Rhythm; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Melatonin; Psychiatric Status Rating Scales; Saliva; Selective Serotonin Reuptake Inhibitors | 2007 |
Effect of antidepressants on melatonin metabolite in depressed patients.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Hypericum; Male; Melatonin; Middle Aged; Plant Extracts; Severity of Illness Index; Thiophenes; Treatment Outcome | 2009 |
Adjuvant use of melatonin for treatment of fibromyalgia.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Fibromyalgia; Fluoxetine; Humans; Male; Melatonin; Middle Aged; Treatment Outcome; Young Adult | 2011 |
Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Adult; Fluoxetine; Humans; Male; Melatonin; Middle Aged; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2014 |
Effects of fluoxetine and melatonin on mood, sleep quality and body mass index in postmenopausal women.
Topics: Affect; Aged; Anxiety; Appetite; Body Mass Index; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Melatonin; Middle Aged; Overweight; Postmenopause; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep; Treatment Outcome | 2015 |
Relationships between circadian measures, depression, and response to antidepressant treatment: A preliminary investigation.
Topics: Adult; Antidepressive Agents; Circadian Rhythm; Depressive Disorder, Major; Female; Fluoxetine; Humans; Light; Male; Melatonin; Sex Factors; Sleep; Treatment Outcome; Young Adult | 2017 |
36 other study(ies) available for fluoxetine and melatonin
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The mechanism of action of vasotocin in the mammalian brain.
Topics: Animals; Cats; Fluoxetine; Humans; Hypothalamus; Injections, Intraventricular; Luteinizing Hormone; Male; Melatonin; Neurons; Oxytocin; Pineal Gland; Prolactin; Rats; Serotonin; Sleep; Time Factors; Vasopressins; Vasotocin | 1979 |
Enhancement of melatonin's antigonadal action by daily injections of the serotonin uptake inhibitor fluoxetine in male hamsters.
Topics: Animals; Circadian Rhythm; Cricetinae; Drug Synergism; Fluoxetine; Injections; Light; Male; Melatonin; Mesocricetus; Organ Size; Periodicity; Propylamines; Serotonin; Serotonin Antagonists; Testis | 1985 |
Effect of fluoxetine on melatonin in patients with seasonal affective disorder and matched controls.
Topics: Adult; Female; Fluoxetine; Humans; Hypothalamus; Male; Melatonin; Receptors, Adrenergic, beta-1; Seasonal Affective Disorder; Treatment Outcome | 1995 |
Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: II. Urinary metabolites of serotonin, norepinephrine, epinephrine and melatonin.
Topics: Adult; Age of Onset; Analysis of Variance; Creatinine; Depressive Disorder; Epinephrine; Female; Fluoxetine; Humans; Male; Melatonin; Middle Aged; Norepinephrine; Prognosis; Reference Values; Serotonin; Treatment Outcome | 1994 |
Lack of effect of short-term fluoxetine administration on nighttime plasma melatonin levels in healthy subjects.
Topics: Administration, Oral; Adult; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Light; Male; Melatonin; Pineal Gland; Serotonin | 1994 |
Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Fenfluramine; Fluoxetine; Injections, Intraperitoneal; Male; Melatonin; Pargyline; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Receptor Agonists; Tryptophan | 1993 |
Evidence for a regulatory role of melatonin on serotonin release and uptake in the pineal gland.
Topics: Animals; Biological Transport; Chromatography, High Pressure Liquid; Denervation; Dose-Response Relationship, Drug; Fluoxetine; Homeostasis; Hydroxyindoleacetic Acid; In Vitro Techniques; Kinetics; Male; Melatonin; Pineal Gland; Rats; Rats, Wistar; Serotonin | 1995 |
Melatonin as a therapeutic agent in the treatment of sleep disturbance in depression.
Topics: Adult; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Melatonin; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 1997 |
Influence of the antidepressants desipramine and fluoxetine on tryptophan-2,3-dioxygenase in the presence of exogenous melatonin.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Fluoxetine; Liver; Male; Melatonin; Rats; Rats, Wistar; Tryptophan Oxygenase | 1998 |
Obsessive-compulsive disorder: evaluation of clinical and biological circadian parameters during fluoxetine treatment.
Topics: Adult; Body Temperature; Circadian Rhythm; Female; Fluoxetine; Humans; Hydrocortisone; Male; Melatonin; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 1999 |
The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H/He mice.
Topics: Animals; Antioxidants; Behavior, Animal; Chronic Disease; Exploratory Behavior; Fluoxetine; Male; Melatonin; Mice; Mice, Inbred C3H; Motor Activity; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Sucrose; Taste; Time Factors | 1999 |
Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin.
Topics: Animals; Antioxidants; Behavior, Animal; Depression; Female; Fluoxetine; Male; Melatonin; Motor Activity; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Sex Characteristics; Swimming | 2000 |
Role of antioxidants in chronic fatigue syndrome in mice.
Topics: Animals; Antioxidants; Brain; Carbazoles; Carvedilol; Catalase; Disease Models, Animal; Fatigue Syndrome, Chronic; Fluoxetine; Glutathione; Glutathione Reductase; Hypericum; Lipid Peroxidation; Male; Melatonin; Mice; Oxidative Stress; Phytotherapy; Propanolamines; Selective Serotonin Reuptake Inhibitors; Superoxide Dismutase; Swimming | 2002 |
Studies on the anti-inflammatory effect of fluoxetine in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Carrageenan; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Edema; Fluoxetine; Foot; Imipramine; Indomethacin; Inflammation; Lactones; Melatonin; Pyrazoles; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sulfonamides; Sulfones; Time Factors; Trazodone | 2004 |
The pineal gland and anxiogenic-like action of fluoxetine in mice.
Topics: Animals; Anxiety Disorders; Arylamine N-Acetyltransferase; Denervation; Fluoxetine; Male; Melatonin; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Pineal Gland; RNA, Messenger; Serotonin; Species Specificity | 2004 |
Maternal fluoxetine infusion does not alter fetal endocrine and biophysical circadian rhythms in pregnant sheep.
Topics: Animals; Blood Pressure; Circadian Rhythm; Electrocardiography; Female; Fluoxetine; Heart Rate; Infusions, Intravenous; Injections, Intravenous; Maternal-Fetal Exchange; Melatonin; Pregnancy; Pregnancy, Animal; Prolactin; Respiration; Selective Serotonin Reuptake Inhibitors; Sheep | 2005 |
Psychopharmacology of synesthesia; the role of serotonin S2a receptor activation.
Topics: Brain; Bupropion; Color Perception; Fluoxetine; Humans; Male; Melatonin; Models, Biological; Models, Theoretical; Perceptual Disorders; Reading; Receptor, Serotonin, 5-HT2A; Visual Perception | 2008 |
Effects of fluoxetine exposure on serotonin-related activity in the sheepshead minnow (Cyprinodon variegatus) using LC/MS/MS detection and quantitation.
Topics: Animals; Chromatography, Liquid; Environmental Exposure; Fluoxetine; Hydroxyindoleacetic Acid; Inhibitory Concentration 50; Killifishes; Melatonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Tandem Mass Spectrometry; Tryptophan | 2009 |
Melatonin treatment of shoulder-and-neck dyskinesia possibly related to fluoxetine treatment.
Topics: Antioxidants; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Male; Melatonin; Neck; Selective Serotonin Reuptake Inhibitors; Shoulder; Young Adult | 2009 |
Agomelatine: new drug. Adverse effects and no proven efficacy.
Topics: Acetamides; Animals; Antidepressive Agents; Bias; Carcinogens; Clinical Trials as Topic; Cyclohexanols; Depression; Depressive Disorder; Double-Blind Method; Drug Approval; Europe; Fluoxetine; Humans; Hypnotics and Sedatives; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptors, Melatonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Melatonin inhibits serotonin transporter activity in intestinal epithelial cells.
Topics: Analysis of Variance; Caco-2 Cells; Citalopram; Fluoxetine; Humans; Intestinal Mucosa; Melatonin; Receptors, Melatonin; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2010 |
Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Apomorphine; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Drug Synergism; Fluoxetine; Haloperidol; Immobility Response, Tonic; Male; Melatonin; Mice; Motor Activity; Sulpiride | 2010 |
Agomelatine in the tree shrew model of depression: effects on stress-induced nocturnal hyperthermia and hormonal status.
Topics: Acetamides; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Body Temperature; Body Weight; Central Nervous System Depressants; Circadian Rhythm; Depressive Disorder; Fever; Fluoxetine; Hydrocortisone; Indoles; Male; Melatonin; Motor Activity; Norepinephrine; Pyridines; Serotonin 5-HT2 Receptor Antagonists; Stress, Psychological; Tupaiidae | 2014 |
Editorial Comment from Dr Sato to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Fluoxetine; Humans; Male; Melatonin; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Editorial Comment from Dr Amano to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Fluoxetine; Humans; Male; Melatonin; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Response to Editorial Comments to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Fluoxetine; Humans; Male; Melatonin; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Protective effects of melatonin on long-term administration of fluoxetine in rats.
Topics: Animals; Antioxidants; Body Weight; Drug-Related Side Effects and Adverse Reactions; Erythrocyte Count; Fluoxetine; Male; Melatonin; Oxidative Stress; Platelet Count; Rats, Wistar | 2017 |
The antidepressant effect of melatonin and fluoxetine in diabetic rats is associated with a reduction of the oxidative stress in the prefrontal and hippocampal cortices.
Topics: Animals; Antidepressive Agents; Anxiety; Depression; Diabetes Mellitus, Experimental; Fluoxetine; Glycated Hemoglobin; Hippocampus; Male; Melatonin; Oxidative Stress; Prefrontal Cortex; Rats, Wistar | 2017 |
Melatonin Augments the Effects of Fluoxetine on Depression-Like Behavior and Hippocampal BDNF-TrkB Signaling.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Depression; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Hippocampus; Male; Melatonin; Membrane Glycoproteins; Mice, Inbred C57BL; Protein-Tyrosine Kinases; Restraint, Physical; Signal Transduction | 2018 |
Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018.
Topics: Adolescent; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Australia; Benzodiazepines; Child; Child, Preschool; Drug Prescriptions; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Melatonin; Primary Health Care; Psychotropic Drugs; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2022 |
Fluoxetine modifies circadian rhythm by reducing melatonin content in zebrafish.
Topics: Animals; Antidepressive Agents; Circadian Rhythm; Fluoxetine; Melatonin; Zebrafish | 2022 |
CYP450 Genetic Polymorphisms: Generalized Tonic-Clonic Seizure after Intentional Fluoxetine and Melatonin Overdose.
Topics: Cytochrome P-450 Enzyme System; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Fluoxetine; Humans; Melatonin; Polymorphism, Genetic; Seizures | 2023 |